CTGF in Pancreatic Stellate Cell-Mediated Fibrogenesis
CTGF in Pancreatic Stellate Cell-Mediated Fibrogenesis
批准号:
7848614
负责人:
DAVID R BRIGSTOCK
金额:
$6.19万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-07-10 至 2011-08-31
关键词:
AcetaldehydeAcinar CellAcuteAcute DiseaseAddressAdhesionsAlcohol consumptionAlcoholic PancreatitisAlcoholsApoptoticAreaAtrophicAutomobile DrivingBindingBiochemicalBiologicalBiological ProcessBiologyCell Proliferation RegulationCell SurvivalCell physiologyCellsCellular biologyChemotaxisChicagoCholelithiasisChondrogenesisChronicCicatrixCollagenConnective TissueContractsDefectDepositionDermalDevelopmentDiseaseDoctor of MedicineDoctor of PhilosophyEndocrineEstersEventExhibitsExtracellular MatrixExtracellular Matrix ProteinsFailureFatty AcidsFibrillar CollagenFibroblastsFibronectinsFibrosisGermanyGlandGrowth Factor ReceptorsIn VitroIncidenceIntegrin alpha5beta1IntegrinsInvestigationKnockout MiceLeadLesionMediatingMediator of activation proteinMedicalMesenchymalModalityModelingMusNecrosisNew YorkOrganPancreasPancreatic DiseasesPancreatic InjuryPancreatitisPathogenesisPathway interactionsPatientsPeptide HydrolasesPlayProcessProductionProgressive DiseaseProliferatingPropertyPublic HealthRegulationRelapseResearch PersonnelRoleSeveritiesSignal TransductionSmooth Muscle Actin Staining MethodStimulation of Cell ProliferationSubcutaneous InjectionsTestingTherapeuticTissuesTransforming Growth Factor betaWorkWound Healingacute pancreatitisalcohol effectangiogenesisautocrinebasecell injurycell typechronic pancreatitisclinically relevantcombatconnective tissue growth factordesignexperiencefibrogenesisin vivomigrationnew therapeutic targetnoveloptimismoxidant stressparacrinepreventresponseresponse to injuryskeletalskillsstellate celltooltransdifferentiationwound
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The broad, long-term objectives are to determine the role played by connective tissue growth factor (CTGF) in promoting pancreatic fibrosis, which is a common feature of chronic pancreatitis. CTGF stimulates vital biological processes such as chondrogenesis, angiogenesis and matrigenesis via its regulation of cell proliferation, migration, transdifferentiation and production of extracellular matrix molecules. CTGF knockout mice exhibit lethal angiogenic and skeletal defects, while subcutaneous injection of CTGF causes dermal fibrosis. CTGF is over-expressed in many fibrotic lesions and acts downstream of transforming growth factor- beta (TGF-beta) in driving fibrosis. During pancreatitis, CTGF is over-expressed by several cell types and acts via autocrine and paracrine pathways to regulate the function of pancreatic stellate cells (PSCs), the principal fibrogenic cell type in the pancreas. CTGF thus holds promise as a new therapeutic target in strategies designed to prevent or reverse pancreatic fibrosis. Our hypothesis is that CTGF production in PSC is stimulated by alcohol and that CTGF drives pro-fibrogenic and anti-apoptotic pathways in PSC through its binding and activation of integrin alpha5beta1 (a5b1), a novel CTGF receptor. The Specific Aims to test this hypothesis are 1. To determine the effect of ethanol and its metabolites on the production of CTGF in PSC; these studies will assess the effect of ethanol, acetaldehyde or fatty acid ethyl esters on CTGF production, the involvement of oxidant stress and TGF-beta, and the role of CTGF in autocrine regulation of PSC function; and 2. To determine the responses of PSC to CTGF and the role of integrin a5b1; these studies will address the expression, regulation, and activation of integrin a5b1 in PSC, will assess the role of integrin a5b1 in mediating pro-fibrogenic and anti-apoptotic signaling in PSC by CTGF, and will assess the role of CTGF in promoting fibrogenesis in vivo when administered against a background of acute pancreatitis in mice. The relevance of these studies to public health is that they will identify the mechanisms by which CTGF regulates PSC function and pancreatic fibrosis, and will thus lead to new treatment modalities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Therapeutic roles of hepatocyte exosomes in the liver
-
批准号:9886400
-
项目类别:
-
资助金额:$40.18万
-
财政年份:2020
-
负责人:DAVID R BRIGSTOCK
-
依托单位:
Therapeutic roles of hepatocyte exosomes in the liver
-
批准号:10582586
-
项目类别:
-
资助金额:$40.98万
-
财政年份:2020
-
负责人:DAVID R BRIGSTOCK
-
依托单位:
Therapeutic roles of hepatocyte exosomes in the liver
-
批准号:10362721
-
项目类别:
-
资助金额:$42.05万
-
财政年份:2020
-
负责人:DAVID R BRIGSTOCK
-
依托单位:
Hepatocyte Exosomes for Therapy of Ethanol-Induced Liver Injury
-
批准号:9370178
-
项目类别:
-
资助金额:$21.63万
-
财政年份:2017
-
负责人:DAVID R BRIGSTOCK
-
依托单位:
Exosome platforms for assessment and therapy of chronic liver disease
-
批准号:8968550
-
项目类别:
-
资助金额:$21.49万
-
财政年份:2015
-
负责人:DAVID R BRIGSTOCK
-
依托单位:
MicroRNA regulation of CTGF in hepatic stellate cells
-
批准号:8438505
-
项目类别:
-
资助金额:$30.3万
-
财政年份:2012
-
负责人:DAVID R BRIGSTOCK
-
依托单位:
MicroRNA regulation of CTGF in hepatic stellate cells
-
批准号:9015720
-
项目类别:
-
资助金额:$32.58万
-
财政年份:2012
-
负责人:DAVID R BRIGSTOCK
-
依托单位:
MicroRNA regulation of CTGF in hepatic stellate cells
-
批准号:8812761
-
项目类别:
-
资助金额:$31.6万
-
财政年份:2012
-
负责人:DAVID R BRIGSTOCK
-
依托单位:
MicroRNA regulation of CTGF in hepatic stellate cells
-
批准号:8625264
-
项目类别:
-
资助金额:$31.6万
-
财政年份:2012
-
负责人:DAVID R BRIGSTOCK
-
依托单位:
MicroRNA regulation of CTGF in hepatic stellate cells
-
批准号:8275273
-
项目类别:
-
资助金额:$32.58万
-
财政年份:2012
-
负责人:DAVID R BRIGSTOCK
-
依托单位:
Mechanisms of CTGF-Induced Liver Disease
-
批准号:8135102
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2010
-
负责人:DAVID R BRIGSTOCK
-
依托单位:
Mechanisms of CTGF-Induced Liver Disease
-
批准号:7799672
-
项目类别:
-
资助金额:$32.08万
-
财政年份:2007
-
负责人:DAVID R BRIGSTOCK
-
依托单位:
Mechanisms of CTGF-Induced Liver Disease
-
批准号:8054761
-
项目类别:
-
资助金额:$30.83万
-
财政年份:2007
-
负责人:DAVID R BRIGSTOCK
-
依托单位:
CTGF in Pancreatic Stellate Cell-Mediated Fibrogenesis
-
批准号:7672571
-
项目类别:
-
资助金额:$31.95万
-
财政年份:2007
-
负责人:DAVID R BRIGSTOCK
-
依托单位:
CTGF in Pancreatic Stellate Cell-Mediated Fibrogenesis
-
批准号:7197190
-
项目类别:
-
资助金额:$31.95万
-
财政年份:2007
-
负责人:DAVID R BRIGSTOCK
-
依托单位:
CTGF in Pancreatic Stellate Cell-Mediated Fibrogenesis
-
批准号:8127648
-
项目类别:
-
资助金额:$30.4万
-
财政年份:2007
-
负责人:DAVID R BRIGSTOCK
-
依托单位:
Mechanisms of CTGF-Induced Liver Disease
-
批准号:7406688
-
项目类别:
-
资助金额:$32.4万
-
财政年份:2007
-
负责人:DAVID R BRIGSTOCK
-
依托单位:
Mechanisms of CTGF-Induced Liver Disease
-
批准号:7600551
-
项目类别:
-
资助金额:$32.4万
-
财政年份:2007
-
负责人:DAVID R BRIGSTOCK
-
依托单位:
CTGF in Pancreatic Stellate Cell-Mediated Fibrogenesis
-
批准号:7502235
-
项目类别:
-
资助金额:$31.95万
-
财政年份:2007
-
负责人:DAVID R BRIGSTOCK
-
依托单位:
Mechanisms of CTGF-Induced Liver Disease
-
批准号:7263604
-
项目类别:
-
资助金额:$32.4万
-
财政年份:2007
-
负责人:DAVID R BRIGSTOCK
-
依托单位:
海外基金